Results 131 to 140 of about 284,324 (192)

Oncolytic viruses in lung cancer: mechanisms of action and research progress. [PDF]

Front Microbiol
Ji T, Hu X, Gao Y, Yu K, He J, Wang L, Gao X.   +6 more
europepmc   +1 more source

Oncolytic viruses: advanced strategies in cancer therapy. [PDF]

Signal Transduct Target Ther
Xiao D, Zhang H, Liu Y, Li Y, Li G, Ning Y.   +5 more
europepmc   +1 more source

The interplay between oncolytic viruses, Toll-like receptor signaling, and chemotherapy in overcoming tumor immune tolerance. [PDF]

Front Cell Infect Microbiol
Wu YY, Wu FH, Tseng CY, Chiang PK, Muniri M, Liu HJ.   +5 more
europepmc   +1 more source

Engineering megakaryocytes with oncolytic viruses for <i>in situ</i> generation of therapeutic platelets. [PDF]

Mol Ther Oncol
Yang Y, Gu Z, Yu J.
europepmc   +1 more source

In silico clinical trials of BiTE expression by oncolytic viruses reveal the impact of patient heterogeneity on dosage protocol. [PDF]

PLoS Comput Biol
Jenner AL, Araujo RP, Levi NL, Ungerechts G, Engeland CE, Heidbuechel JPW.   +5 more
europepmc   +1 more source

Neoantigen-Encoded Oncolytic Viruses as Personalized Cancer Vaccines. [PDF]

Pharmaceuticals (Basel)
Alkayyal AA.
europepmc   +1 more source

From monoclonal to polyfunctional immunotherapy: Reprogramming CAR-T-cell therapy with oncolytic viruses in B-cell malignancies. [PDF]

Hemasphere
Achim E, Ungerechts G, Tomuleasa C, Friedel S, Hudecek M, Cristea C, Tertis M, Einsele H.   +7 more
europepmc   +1 more source

Enhancing antitumor immunity through oncolytic viruses: advances in genetic engineering. [PDF]

Discov Oncol
Zubair A, Lazarou L, Alkahtani AM, Shahani MY, Afghan N.   +4 more
europepmc   +1 more source

Oncolytic viruses and neoantigen vaccines: opportunities and challenges in priming antitumour immunity. [PDF]

Lancet Reg Health Eur
Mansinho A, Albuquerque J, Calvo E.
europepmc   +1 more source

Reprogramming the immune orchestra for glioblastoma: oncolytic viruses and the B-cell connection. [PDF]

Cell Mol Immunol
Dieli C, Di Simone M, Dieli F, Meraviglia S.   +3 more
europepmc   +1 more source